Literature DB >> 23733917

Mechanistic features associated with improvement in mitral regurgitation after cardiac resynchronization therapy and their relation to long-term patient outcome.

Tetsuari Onishi1, Toshinari Onishi, Josef J Marek, Mohamed Ahmed, Stephanie C Haberman, Olusegun Oyenuga, Evan Adelstein, David Schwartzman, Samir Saba, John Gorcsan.   

Abstract

BACKGROUND: Mechanisms of mitral regurgitation (MR) reduction with cardiac resynchronization therapy (CRT) are complex, and their association with long-term outcome is unclear. We sought to elucidate mechanistic features of reduction in MR with CRT, which impact long-term patient survival. METHODS AND
RESULTS: A prospective longitudinal study of 277 patients with heart failure with QRS width ≥ 120 ms and ejection fraction ≤ 35% for CRT was performed. Quantitative echocardiography, including dyssynchrony analysis, was performed at baseline. MR was quantified by color Doppler before and 6 months after CRT. Predefined end points of death, transplant, or left ventricular assist device were tracked during 4 years. There were 114 (48%) patients with CRT with significant MR (≥ moderate) at baseline; of whom 48 (42%) patients had MR improvement, and 24 (19%) patients had MR worsening after CRT. The 66 events (47 deaths, 10 transplantations, and 9 left ventricular assist devices) were strongly associated with significant MR after CRT (hazard ratio, 3.58; 95% confidence interval, 2.18-5.87; P<0.0001). Three echocardiographic features were independently associated with amelioration of significant MR after CRT by multivariable analysis: anteroseptal to posterior wall radial strain dyssynchrony >200 ms, lack of severe left ventricular dilatation (end-systolic dimension index <29 mm/m(2)), and lack of echocardiographic scar at papillary muscle insertion sites (all P<0.05) and, when combined, were additively associated with long-term survival (P=0.0001).
CONCLUSIONS: Significant MR after CRT was strongly associated with less favorable long-term survival. Echocardiographic mechanistic features were identified that were associated with improvement in MR after CRT and favorable long-term survival.

Entities:  

Keywords:  cardiac resynchronization therapy; echocardiography; mitral valve insufficiency

Mesh:

Year:  2013        PMID: 23733917     DOI: 10.1161/CIRCHEARTFAILURE.112.000112

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  17 in total

Review 1.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 2.  Ischemic and functional mitral regurgitation in heart failure: natural history and treatment.

Authors:  Mina M Benjamin; Robert L Smith; Paul A Grayburn
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

Review 3.  Mechanical dyssynchrony and deformation imaging in patients with functional mitral regurgitation.

Authors:  Isabella Rosa; Claudia Marini; Stefano Stella; Francesco Ancona; Marco Spartera; Alberto Margonato; Eustachio Agricola
Journal:  World J Cardiol       Date:  2016-02-26

Review 4.  Treatment of Functional Mitral Regurgitation in Heart Failure.

Authors:  Enrico Fabris; Antonio De Luca; Giancarlo Vitrella; Davide Stolfo; Marco Masè; Renata Korcova; Marco Merlo; Serena Rakar; Arnoud W J Van't Hof; Elvin Kedhi; Andrea Perkan; Gianfranco Sinagra
Journal:  Curr Cardiol Rep       Date:  2019-11-16       Impact factor: 2.931

5.  Assessment of dyssynchrony by gated myocardial perfusion imaging does not improve patient management.

Authors:  Ran Lee; Ravi V Shah; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2017-08-08       Impact factor: 5.952

6.  Novel Heart Failure Biomarkers Predict Improvement of Mitral Regurgitation in Patients Receiving Cardiac Resynchronization Therapy-The BIOCRT Study.

Authors:  Jonathan Beaudoin; Jagmeet P Singh; Jackie Szymonifka; Qing Zhou; Robert A Levine; James L Januzzi; Quynh A Truong
Journal:  Can J Cardiol       Date:  2016-06-02       Impact factor: 5.223

7.  Left ventricular wall thickness assessed by cardiac computed tomography and cardiac resynchronization therapy outcomes.

Authors:  Vincent Galand; Brian Ghoshhajra; Jackie Szymonifka; Saumya Das; Mary Orencole; Valentin Barré; Raphaël P Martins; Christophe Leclercq; Judy Hung; Quynh A Truong; Jagmeet P Singh
Journal:  Europace       Date:  2020-03-01       Impact factor: 5.214

Review 8.  Ischemic Mitral Regurgitation: A Multifaceted Syndrome with Evolving Therapies.

Authors:  Mattia Vinciguerra; Francesco Grigioni; Silvia Romiti; Giovanni Benfari; David Rose; Cristiano Spadaccio; Sara Cimino; Antonio De Bellis; Ernesto Greco
Journal:  Biomedicines       Date:  2021-04-21

9.  Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K⁺ channel-deficient dilated cardiomyopathy.

Authors:  Satsuki Yamada; D Kent Arrell; Garvan C Kane; Timothy J Nelson; Carmen M Perez-Terzic; Atta Behfar; Saranya Purushothaman; Frits W Prinzen; Angelo Auricchio; Andre Terzic
Journal:  J Am Heart Assoc       Date:  2013-12-05       Impact factor: 5.501

10.  Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy-incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial.

Authors:  Jacek Kowalczyk; Radoslaw Lenarczyk; Oskar Kowalski; Tomasz Podolecki; Pawel Francuz; Patrycja Pruszkowska-Skrzep; Mariola Szulik; Michal Mazurek; Ewa Jedrzejczyk-Patej; Beata Sredniawa; Zbigniew Kalarus
Journal:  J Interv Card Electrophysiol       Date:  2014-03-14       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.